Cardio Diagnostics Holdings, Inc.·4

Apr 2, 2:03 PM ET

Burton Paul Frederick 4

4 · Cardio Diagnostics Holdings, Inc. · Filed Apr 2, 2026

Research Summary

AI-generated summary of this filing

Updated

Cardio Diagnostics (CDIO) Director Burton Frederick Receives Award of 3,205 Shares

What Happened

  • Burton Paul Frederick, a director of Cardio Diagnostics Holdings, Inc. (CDIO), was reported on Form 4 as acquiring 3,205 shares on March 31, 2026. The shares are recorded at $1.95 each, for a total reported value of $6,250.
  • The transaction is coded as an "A" (award/grant/other acquisition), indicating the shares were received through an award or similar issuance (a derivative settlement or grant), not an open-market purchase or sale.

Key Details

  • Transaction date: 2026-03-31; Filing date: 2026-04-02 (filed within the standard Form 4 window).
  • Price per share: $1.95; Shares acquired: 3,205; Reported total value: $6,250.
  • Shares owned after the transaction: not specified in the provided filing excerpt.
  • Footnotes/tax withholding: none reported in the excerpt provided.
  • Transaction type code: A = Award/Grant/Other acquisition (derivative/compensation-related).

Context

  • Awards to directors are typically part of compensation or equity-based retention plans and do not necessarily indicate the insider's short-term trading view. The dollar value here is modest (~$6.3k).
  • For retail investors, treat awards differently from open-market purchases: awards signal company compensation decisions, while outright purchases may be a stronger indication of personal conviction.

Insider Transaction Report

Form 4
Period: 2026-03-31
Transactions
  • Award

    Stock Options (Right to Buy)

    2026-03-31$1.95/sh+3,205$6,25010,464 total
    Exercise: $1.95From: 2026-03-31Exp: 2036-03-31Common Stock (3,205 underlying)
Signature
/s/ Elisa Luqman as attorney-in-fact for Paul Burton|2026-04-02

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT